Ernesto Aycardi
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ernesto Aycardi
The proxy statement of Xenon Pharmaceuticals Inc. reports total compensation of $1,106,739 for Ernesto Aycardi in fiscal 2020, including a base salary of $434,700. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Xenon Pharmaceuticals Inc. (XENE)
Proxy statement
Start not stated–2021-04-28
Last confirmed by a filing; no departure on record
-
Xenon Pharmaceuticals Inc. (XENE)
Proxy statement
Start not stated–2021-04-23
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | $434,700 | $1,106,739 |
| 2019 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | $419,991 | $1,072,977 |
| 2018 | Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | $316,667 | $692,011 |
Recent activity
No call appearances or filed executive changes recorded yet.